← Leaderboards
Amanda J Shallcross
University Of Denver (Colorado Seminary)
$3,558,043
Attributed
$7,020,334
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.1M · FY2010–24$5M$3.8M$2.5M$1.3M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$7,020,334 · 4
By mechanism
R01$3,080,247 · 1
U01$2,883,251 · 1
K23$835,844 · 1
F32$220,992 · 1
Top collaborators
- Elizabeth K Seng-Tamaccio5 shared
- David M Charytan1 shared
- Joshua D Lee1 shared
Others in their field
Top investigators on “Design”
- Lawrence Corey · Fred Hutchinson Cancer Center$736,542,541
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$460,267,569
- Jeffrey P Krischer · University Of South Florida$427,700,530
- David R. Weir · University Of Michigan At Ann Arbor$385,316,144
Research focus
DesignMental DepressionTrainingEmotionalDepressive SymptomsInterviewEvidence BasePrimary OutcomeResearch PersonnelChronicUnited States National Institutes Of HealthTelephoneTreatment As UsualChronic DiseaseMindfulness Based Cognitive TherapyQuestionnairesResearch DesignBehavioralClient SatisfactionHypertensionDisabilityReportingMind-Body InterventionArea
Grant awards (14)
Feasibility and Acceptability of Telephone-delivered MBCT for Migraine and Depression (FATE-MD)$710,505
R01 · FY2024 · AT · contact PI
Feasibility and Acceptability of Telephone-delivered MBCT for Migraine and Depression (FATE-MD)$112,919
R01 · FY2024 · AT · contact PI
Feasibility and Acceptability of Telephone-delivered MBCT for Migraine and Depression (FATE-MD)$737,957
R01 · FY2023 · AT · contact PI
Feasibility and Acceptability of Telephone-delivered MBCT for Migraine and Depression (FATE-MD)$733,229
R01 · FY2022 · AT · contact PI
Feasibility and Acceptability of Telephone-delivered MBCT for Migraine and Depression (FATE-MD)$785,637
R01 · FY2021 · AT · contact PI
A telephone-delivered mindfulness intervention for patients with comorbid depression and chronic disease$174,546
K23 · FY2020 · AT · contact PI
Pain, Opioids, and ESRD risk reduction with Mindfulness and Buprenorphine (POEM-B): A 3-arm multi-site randomized trial in hemodialysis patients$2,883,251
U01 · FY2019 · DK
A telephone-delivered mindfulness intervention for patients with comorbid depression and chronic disease$174,546
K23 · FY2019 · AT · contact PI
A telephone-delivered mindfulness intervention for patients with comorbid depression and chronic disease$174,546
K23 · FY2018 · AT · contact PI
A telephone-delivered mindfulness intervention for patients with comorbid depression and chronic disease$174,546
K23 · FY2017 · AT · contact PI
A telephone-delivered mindfulness intervention for patients with comorbid depression and chronic disease$137,660
K23 · FY2016 · AT · contact PI
The Effects and Mechanisms of MBCT on Depressive Symtoms and Depression Relapse$76,432
F32 · FY2012 · AT · contact PI
The Effects and Mechanisms of MBCT on Depressive Symtoms and Depression Relapse$73,750
F32 · FY2011 · AT · contact PI
The Effects and Mechanisms of MBCT on Depressive Symtoms and Depression Relapse$70,810
F32 · FY2010 · AT · contact PI